Home / CANCER BUZZ Podcast

CANCER BUZZ Podcast

Want the latest BUZZ? Just listen in!

The CANCER BUZZ podcast features fresh perspectives on hot topics in oncology care delivery. CANCER BUZZ is where stakeholders from the front lines of care to the C-suite, from research to the registry, from chairside to benchside, talk about top-of-mind questions and real-world impact.

Listen to the CANCER BUZZ podcast on Apple Podcasts, Spotify, Amazon Music, or wherever you get your podcasts. You can now listen with your smart home device. For instructions on how to listen with Alexa, click here, or just tell Alexa to "Play CANCER BUZZ." For Google Home instructions, click here.

Filter By Topic

Filter By Podcast Format

 
 
 
 
 
CANCER BUZZ spoke to Allison Applebaum, PhD, Psychologist, Memorial Sloan Kettering Cancer Center in New York City, NY. Listen as Dr. Applebaum discusses practical tips providers can use to support caregiver empowerment.
To standardize comprehensive biomarker testing in patients with NSCLC, Oncology Hematology Care, Inc., developed and implemented a 1-year quality improvement (QI) project that included custom data reports and monitoring dashboards to ensure practice-wide adoption and sustainability across multiple clinic sites.
The rapid evolution of cancer care delivery toward multi-agent regimens, oral and/or combination therapies, and at-home treatment administration has made cancer caregiving extremely complex. The Caregiver Clinic at Memorial Sloan Kettering provides support to people who are having difficulty coping with the demands of being a caregiver. The purpose of this clinic is to help individuals maximize their …
At Duke Cancer Institute, the implementation of electronic-consults for patients experiencing endocrine irAEs improved patient access and reduced healthcare utilization.
Listen as we discuss nursing’s role in the care of patients with small cell lung cancer (SCLC).
For several years, this healthcare system struggled to find a sustainable program to perform outreach to patients with outstanding orders for lung, breast, and colon cancer screenings.
Caregivers experience higher levels of financial, emotional, and physical health difficulties than non-caregivers and are more likely to suffer from depressive symptoms and mental health problems. The Caregivers Clinic at Memorial Sloan Kettering Cancer Center is the first of its kind and provides comprehensive psychosocial care to family members and friends of patients who experience significant distress …
Learn how the creation of the first advanced practice radiation therapist (APRT) role in the United States established a new model of inpatient care, elevating the radiation therapy skill set and allowing for intervention at key points along the radiation oncology care pathway.
In this episode, hear about the fully remote TRACK (Target Rare Cancer Knowledge) clinical trial and its unique approach to providing access to biomarker testing for patients in community care settings by leveraging technology.
CANCER BUZZ speaks with Susan Spinosa, president and patient founder of NTRKers, an organization created to support patients with NTRK fusion-positive cancer, about her care journey and the importance of testing for NTRK gene fusions.
Personalizing care goals to account for a patient’s values, preferences, or circumstances can make a significant difference in shared decision-making and treatment planning. In this episode, CANCER BUZZ speaks with Melissa Kah Poh Loh, MBBCh, BAO, assistant professor of Geriatric Hematology and Oncology at the University of Rochester Medical Center’s Wilmot Cancer Institute about strategies …
Significant declines in the screening, diagnosis, and treatment of patients with small cell lung cancer have increased challenges that impact patient care. Many patients with small cell lung cancer have a high symptom burden, poor prognosis, adherence challenges due to treatment-related adverse events, stigmatization, and emotional distress. The team at Atrium Health’s Levine Cancer Institute …
Mary B. Battaglia has been practicing clinical hypnosis for 10 years, working with clients to address issues like anxiety and stress and supported people with different medical issues, including brain, breast, lung, prostate, and skin cancers.
While there are many factors why patients with acute myeloid leukemia are ineligible for allogeneic stem cell transplant, such as age, financial hurdles, or other comorbidities, these factors are often compounded by social determinants of health, which can act as a significant barrier to consolidation therapy and long-term remission for these patients. In this episode, CANCER BUZZ speaks with Keri …
Working under the hypothesis that a subset of de novo oligometastatic breast cancer patients who are treated with a combination of systemic therapy, surgery, and radiation or ablation of metastatic sites will have long-term distant metastasis free and overall survival, this multi-cohort, prospective, nationwide registry study will enroll newly diagnosed oligometastatic HER2+ breast cancer …
As biomarker testing can play a critical role in the diagnosis of rare cancers, such as NTRK gene fusion-positive cancers, hear what care teams need to know about identifying patients who may be eligible for this testing.
Breaking down the social stigma that is often still associated with seeking mental health services is key to making cancer care clinicians and staff feel a "sense of safety" and that they will not be penalized for accessing mental health services.
In 2022, ACCC conducted a survey to measure patient, caregiver, and provider perceptions and adoption of messaging tools, electronic questionnaires, and connected devices used to track and monitor symptoms during cancer treatment.
As myeloproliferative neoplasms (MPNs) carry a heavy symptom burden which can significantly impact a patient’s quality of life, hear how multidisciplinary care and psycho-social support can help alleviate this burden for patients.
The goal of treatment for most patients with myelofibrosis is to relieve symptoms. Hear Dr. Gerds discuss standard of care treatment options and new therapies for treating patients with myelofibrosis.
The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Community Cancer Centers.